In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Rybelsus® (Semaglutide, Oral tablet) by Novo Nordisk has been FDA-approved since 2019 for Type 2 diabetes. Weight Method offers a separate option for Los Altos residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month — same pricing regardless of location.
FDA-approved Rybelsus prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Los Altos is already seeing results
Rybelsus in Los Altos, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Rybelsus to patients in Los Altos from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Rybelsus® as the FDA-approved Oral tablet product, taken Once daily, approved in 2019. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible Los Altos, CA residents starts at $199/month.
Los Altos's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Rybelsus® is the FDA-approved Oral tablet Semaglutide product manufactured by Novo Nordisk since 2019. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Semaglutide delivered to your Los Altos address at $199/month. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.